Low-burden subclonal mutations in the TP53 gene have been identified in various B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma, and follicular lymphoma [39,40]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.